Literature DB >> 17357809

False positive 18F-FDG PET/CT due to gynaecomastia.

R Ramtahalsing1, A I J Arens, R F A Vliegen, G J J Teule, P L A van den Ende, R G H Beets-Tan.   

Abstract

Mesh：

Substances：

Year:  2006        PMID： 17357809     DOI： 10.1007/s00259-006-0263-7

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  4 in total

1.  Ga-67 citrate and F-18 FDG uptake in spironolactone-induced gynecomastia.

Authors:  Kazuki Fukuchi; Hideyuki Sasaki; Takahiro Yokoya; Teruo Noguchi; Yoichi Goto; Kohei Hayashida; Yoshio Ishida
Journal:  Clin Nucl Med       Date:  2005-02       Impact factor: 7.794

2.  Factors influencing [F-18] 2-fluoro-2-deoxy-D-glucose (F-18 FDG) uptake in melanoma cells: the role of proliferation rate, viability, glucose transporter expression and hexokinase activity.

Authors:  Kiyoshi Yamada; Ingo Brink; Emmanuel Bissé; Thomas Epting; Rupert Engelhardt
Journal:  J Dermatol       Date:  2005-05       Impact factor: 4.005

Review 3.  Current status of PET in breast cancer imaging, staging, and therapy.

Authors:  R L Wahl
Journal:  Semin Roentgenol       Date:  2001-07       Impact factor: 0.800

4.  Subcutaneous metastases from malignant melanoma: prevalence and findings on CT.

Authors:  R M Patten; W P Shuman; S Teefey
Journal:  AJR Am J Roentgenol       Date:  1989-05       Impact factor: 3.959
  4 in total
  1 in total

1.  Spectrum of the Breast Lesions With Increased 18F-FDG Uptake on PET/CT.

Authors:  Aisheng Dong; Yang Wang; Jianping Lu; Changjing Zuo
Journal:  Clin Nucl Med       Date:  2016-07       Impact factor: 7.794
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.